Alessandra Ferrario is a Postdoctoral Research Fellow at Harvard Medical School and Harvard Pilgrim Health Care Institute where she conducts research on the intensity of end-of-life care for breast cancer patients. She has been working as a Research Officer at London School of Economics (LSE) from 2011 to 2017 on pharmaceutical policy issues and non-communicable diseases. Alessandra’s PhD investigated issues around access to new cancer medicines in Europe. In particular, cross-country variations in access, the use of risk-sharing and managed entry agreements. Alessandra has worked with the World Health Organization on pricing and procurement at global and European level and on availability, affordability and quality use of medicines in Estonia, the Republic of Moldova and Tajikistan. She holds a PhD from the London School of Economics, an MSc in Health Policy, Planning and Financing (LSE/LSHTM), MSc in Epidemiology (Swiss Tropical and Public Health Institute, University of Basel) and BSc in Molecular Biology (University of Basel).